Usporedite metode
Pregledajte odabrane metode jednu uz drugu; retci koji se razlikuju su istaknuti.
| Analiza snage utemeljena na simulaciji (snaga Monte Carla)× | Sekvencijalna analiza (Grupni sekvencijalni dizajn)× | |
|---|---|---|
| Područje | Statistika | Statistika |
| Obitelj | Hypothesis test | Hypothesis test |
| Godina nastanka≠ | 2011 | 1977 |
| Tvorac≠ | Arnold et al. (2011); Green & MacLeod (2016) for mixed-model extension | P. C. O'Brien & T. R. Fleming; P. C. Pocock |
| Vrsta≠ | Simulation-based (Monte Carlo) | Sequential / adaptive hypothesis test |
| Temeljni izvor≠ | Arnold, B.F. et al. (2011). Simulation Methods to Estimate Design Power: An Overview for Applied Research. BMC Medical Research Methodology, 11, 94. DOI ↗ | O'Brien, P.C. & Fleming, T.R. (1979). A Multiple Testing Procedure for Clinical Trials. Biometrics, 35(3), 549–556. DOI ↗ |
| Drugi nazivi | Monte Carlo power analysis, Monte Carlo simulation power, MC power, Simülasyon Tabanlı Güç Analizi (Monte Carlo Power) | sequential testing, group sequential design, interim analysis, Sıralı Analiz (Sequential Testing / Group Sequential Design) |
| Srodne≠ | 6 | 5 |
| Sažetak≠ | Simulation-based power analysis estimates the statistical power and required sample size of a study by repeating a full analysis pipeline thousands of times on artificially generated data. Because it relies on Monte Carlo simulation rather than closed-form equations, it is applicable to designs — mixed models, complex measurement structures, non-standard outcomes — where analytical power formulas do not exist. The approach was systematically described for applied research by Arnold et al. in 2011, and the mixed-model implementation via the SIMR package was formalised by Green and MacLeod in 2016. | Sequential analysis is a framework for conducting hypothesis tests with pre-planned interim looks at accumulating data, allowing a study to stop early for efficacy or futility while controlling the overall Type I error rate. The group sequential approach was formalised by Pocock (1977) and O'Brien and Fleming (1979), and remains the standard for confirmatory clinical trials and rigorous A/B experiments. |
| ScholarGateSkup podataka ↗ |
|
|